Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Warner Bros
WBD
|
+$130M |
| 2 |
Tesla
TSLA
|
+$76.4M |
| 3 |
Roblox
RBLX
|
+$50.1M |
| 4 |
VICI Properties
VICI
|
+$43.2M |
| 5 |
Danaher
DHR
|
+$41.2M |
Top Sells
| 1 |
AT&T
T
|
+$209M |
| 2 |
CERN
Cerner Corp
CERN
|
+$119M |
| 3 |
Baidu
BIDU
|
+$91.9M |
| 4 |
Canadian National Railway
CNI
|
+$53.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$37.5M |
Sector Composition
| 1 | Technology | 26.45% |
| 2 | Healthcare | 15.87% |
| 3 | Consumer Discretionary | 11.68% |
| 4 | Communication Services | 8.96% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Lindblad Expeditions
LIND
$767M
| $630K | ﹤0.01% |
77,741
+6,500
| +9% | +$52.7K |
|
|
LGO
2552
Largo
LGO
$95.6M
| $628K | ﹤0.01% |
92,110
+7,400
| +9% | +$50.5K |
|
2553
Microvast
MVST
$910M
| $628K | ﹤0.01% |
283,100
-36,700
| -11% | -$81.4K |
|
2554
EverCommerce
EVCM
$2.12B
| $624K | ﹤0.01% |
+69,000
| New | +$624K |
|
2555
Centrus Energy
LEU
$3.97B
| $624K | ﹤0.01% |
25,200
| – | – |
|
2556
Caribou Biosciences
CRBU
$169M
| $621K | ﹤0.01% |
114,400
+57,400
| +101% | +$312K |
|
2557
Donegal Group Class A
DGICA
$704M
| $621K | ﹤0.01% |
36,400
+2,900
| +9% | +$49.5K |
|
2558
Repare Therapeutics
RPTX
$73.5M
| $620K | ﹤0.01% |
44,300
+4,800
| +12% | +$67.2K |
|
2559
CS Disco
LAW
$355M
| $619K | ﹤0.01% |
+34,300
| New | +$619K |
|
2560
Adicet Bio
ACET
$63.5M
| $618K | ﹤0.01% |
+42,300
| New | +$618K |
|
|
SBOW
2561
DELISTED
SilverBow Resources, Inc.
SBOW
| $618K | ﹤0.01% |
+21,800
| New | +$618K |
|
2562
BioXcel Therapeutics
BTAI
$52.1M
| $611K | ﹤0.01% |
2,894
| – | – |
|
|
INBX
2563
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $608K | ﹤0.01% |
53,600
+31,100
| +138% | +$353K |
|
2564
Kodiak Sciences
KOD
$517M
| $607K | ﹤0.01% |
79,500
+6,100
| +8% | +$46.6K |
|
2565
C4 Therapeutics
CCCC
$193M
| $606K | ﹤0.01% |
80,400
+51,600
| +179% | +$389K |
|
2566
Rush Street Interactive
RSI
$1.99B
| $606K | ﹤0.01% |
129,700
+3,600
| +3% | +$16.8K |
|
2567
Gilat Satellite Networks
GILT
$611M
| $602K | ﹤0.01% |
100,665
+26,716
| +36% | +$160K |
|
2568
Kodak
KODK
$467M
| $602K | ﹤0.01% |
129,700
+36,800
| +40% | +$171K |
|
2569
Couchbase
BASE
$1.35B
| $599K | ﹤0.01% |
36,500
+10,700
| +41% | +$176K |
|
2570
MiMedx Group
MDXG
$1.06B
| $598K | ﹤0.01% |
172,400
| – | – |
|
|
QUOT
2571
DELISTED
Quotient Technology Inc
QUOT
| $595K | ﹤0.01% |
200,200
+10,400
| +5% | +$30.9K |
|
2572
Groupon
GRPN
$920M
| $590K | ﹤0.01% |
52,178
-7,300
| -12% | -$82.5K |
|
2573
Perella Weinberg Partners
PWP
$1.41B
| $586K | ﹤0.01% |
100,500
+14,800
| +17% | +$86.3K |
|
|
CINC
2574
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $586K | ﹤0.01% |
+31,100
| New | +$586K |
|
2575
Hippo Holdings
HIPO
$916M
| $584K | ﹤0.01% |
26,608
| – | – |
|